Ipca Laboratories reports 86% fall in Q1 net profit

30 Jul 2015 Evaluate

Ipca Laboratories has reported results for first quarter ended June 30, 2015.

The company has reported a fall of 86.19% in its net profit at Rs 18.89 crore for the quarter ended June 30, 2015 as compared to Rs 136.74 crore for the same quarter in the previous year. The company’s total income has decreased by 19.12% to Rs 762.10 crore for the quarter under review, from Rs 942.25 crore for the corresponding quarter of the previous year.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1332.70 -17.70 (-1.31%)
03-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.00
Dr. Reddys Lab 6332.85
Cipla 1424.40
Zydus Lifesciences 992.00
Lupin 1663.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.